HopeStage
Back to overview

Bipolarity studies

Topics
More filters

Bipolarity

Bipolarity involves episodes of depression and periods of elevated or irritable mood, with unusually high energy and activity.

1979studies shown
Showing 577-588 of 1,979
Other study type icon
CompletedNCT02350452

Impact on Ovarian Reserve of Diode Laser vs Bipolar Coagulation of Endometriomas

Official study title

The Impact on Ovarian Reserve of Diode Laser vs Bipolar Coagulation of Inner Lining of Ovarian Endometriomas After Laparoscopic Cystectomy: a Randomized Clinical Trial.

This study has finished and is no longer accepting participants.

In Monserrato
BipolarityInterventional studyAges 18–40
Countries
Italy
Sponsor
University of Cagliari
Drug study icon
CompletedNCT00845988

Metabolic Effects of Switching to Aripiprazole in people with Bipolarity

Official study title

Metabolic Effects of Switching to Aripiprazole in Patients With Bipolar Disorders Having Drug-induced Weight Gain

This study has finished and is no longer accepting participants.

In Seongnam-si
BipolarityMedication studyAges 18–65
Countries
South Korea
Sponsor
Seoul National University Hospital
Behavioral study icon
CompletedNCT03249857

Sensorimotor Compatibility Effects in Bipolarity.

Official study title

Study of Sensorimotor Compatibility Effects in Bipolar Affective Disorder.

This study has finished and is no longer accepting participants.

In Saint-Etienne
BipolarityBehavioural studyAges 18–55
Countries
France
Sponsor
Centre Hospitalier Universitaire de Saint Etienne
Drug study icon
CompletedEUCTR 2012-004334-42

A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients with Bipolarity type I

Official study title

A 52-week, Multicenter, Open-label Study to Evaluate the Effectiveness of an Intramuscular Depot Formulation of Aripiprazole (OPC-14597) as Maintenance Treatment in Patients with Bipolar I Disorder

Original registry wording; source language not specified.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Hungary
BipolarityHistorical research record
Countries
Hungary
Sponsor
Otsuka Pharmaceutical Development & Commercialization, Inc. (Pharmaceutical company)
Drug study icon
CompletedEUCTR 2005-004167-27

A Phase 3, randomized, 6-month, double blind trial in subjects with Bipolarity type I to evaluate the continued safety and maintenance of effect of Ziprasidone plus a mood stabilizer (vs placebo p...

Official study title

A Phase 3, randomized, 6-month, double blind trial in subjects with Bipolar I Disorder to evaluate the continued safety and maintenance of effect of Ziprasidone plus a mood stabilizer (vs placebo p...

Original registry wording; source language not specified.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Germany
BipolarityHistorical research record
Countries
Germany, Italy, Spain, + 1 other
Sponsor
Pfizer, S.A.
Drug study icon
CompletedEUCTR 2004-003781-14

A Randomized, Double-Blind, Placebo-Controlled Study to Explore the Efficacy and Safety of Risperidone Long-Acting Intramuscular Injectable in the Prevention of Mood Episodes in Bipolarity type I,...

Official study title

A Randomized, Double-Blind, Placebo-Controlled Study to Explore the Efficacy and Safety of Risperidone Long-Acting Intramuscular Injectable in the Prevention of Mood Episodes in Bipolar I Disorder,...

Original registry wording; source language not specified.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Austria
BipolarityHistorical research record
Countries
Austria, Slovakia, Spain
Sponsor
Johnson & Johnson Pharmaceutical Research and Development
Drug study icon
CompletedEUCTR 2009-017581-22

Aripiprazole and cognition in bipolarity

What is this study about?

A historical medicine-trial record describes research on cognition during aripiprazole treatment.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Germany
BipolarityHistorical medicine trial
Countries
Germany
Sponsor
Department of Psychiatry and Psychotherapy, Charity University Medicine
Drug study icon
CompletedEUCTR 2005-002134-35

EXTENSION STUDY TO INVESTIGATE THE EFFICACY, SAFETY AND TOLERABILITY OF ESLICARBAZEPINE ACETATE (BIA 2-093) IN THE RECURRENCE PREVENTION OF Bipolarity type I

Official study title

EXTENSION STUDY TO INVESTIGATE THE EFFICACY, SAFETY AND TOLERABILITY OF ESLICARBAZEPINE ACETATE (BIA 2-093) IN THE RECURRENCE PREVENTION OF BIPOLAR I DISORDER

Original registry wording; source language not specified.

This study has finished and is no longer accepting participants.

Historical country statuses are shown below. They describe the trial's progress and do not confirm open recruitment.

In Austria
BipolarityHistorical research record
Countries
Austria, Czechia, Germany, + 3 others
Sponsor
Bial - Portela & Cª, S.A.

Registry coverage

We gather information about mental health clinical trials from the public registries we index. Coverage is still expanding, so some studies may not appear yet.